Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 48.84  0.00  0.00%   
About 55% of Ascendis Pharma's investor base is interested to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are impartial regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Mackenzie Financial Corp Cuts Stock Holdings in Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Looking Into Ascendis Pharmas Recent Short Interest - Ascendis Pharma - Benzinga
Google News at Macroaxis
over six months ago at news.google.com         
abrdn plc Makes New 17.48 Million Investment in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma Gains UK Authorization for YORVIPATH - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Rating Reiterated by Morgan Stanley - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Stock Position Reduced by Allspring Global Investments Holdings LLC - Defense Wor...
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Outlines Financial Strategy - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Receives Average Recommendation of Moderate Buy from Analysts - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Some Confidence Is Lacking In Ascendis Pharma AS PS - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Heres How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years - Investing.com...
Google News at Macroaxis
over six months ago at news.google.com         
Growth Stock With 520 percent Sales Gain Nears Next Buy Point - Investors Business Daily
Google News at Macroaxis
over six months ago at news.google.com         
Does Ascendis Pharma AS Have the Potential to Rally 35 percent as Wall Street Analysts Expect - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Two Health Care Companies Outperform SP 500, Offer Entries - Investors Business Daily
Google News at Macroaxis
over six months ago at news.google.com         
Wells Fargo Company Boosts Ascendis Pharma AS Price Target to 260.00 - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world